Learning from Prozac: A Case Study on Reforming the FDA Drug Approval Process

DSpace/Manakin Repository

Learning from Prozac: A Case Study on Reforming the FDA Drug Approval Process

Citable link to this page

. . . . . .

Title: Learning from Prozac: A Case Study on Reforming the FDA Drug Approval Process
Author: Wood, Maria
Citation: Learning from Prozac: A Case Study on Reforming the FDA Drug Approval Process (1997 Third Year Paper)
Full Text & Related Files:
Abstract: The law, focused as it is on making final determinations and settling issues one way or another, continually lags behind science, which concentrates on an evolving understanding of various phenomena through constant enhancement of current understandings of existing realities. Thus, a drug approval process, which obviously deals with scientific issues of drug development, cannot always keep pace with scientific understandings of drug development. The law is flexible and capable of accommodating new understandings, though; therefore, consideration of the scientific issues involved in drug development and approval is appropriate and ought to be undertaken as much as possible in order to develop legal answers that are as accurate as they can be at any given time.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846814

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters